Suruchi Shrestha joins the lab!

The lab is excited to welcome Bhawana Shrestha (Suruchi) as the newest member of our team! She joins us as a Scientist to develop peptide- and antibody-based therapeutics for solid tumors.

Before joining Stanford, Suruchi earned her Ph.D. in Microbiology and Immunology at the University of North Carolina at Chapel Hill. Her doctoral research focused on engineering novel multivalent antibodies against sperm as a much-needed non-hormonal contraceptive. She is a co-inventor on the resulting patent, which has been licensed by Inhalon and Mucommune Biopharma.

After completing her Ph.D., Suruchi worked as a Scientist at NextVivo, where she developed human lymphoid organoids for antibody discovery against self-antigens and advanced air–liquid interface organoid models for tumor-infiltrating lymphocyte (TIL) therapy in solid tumors.

She is excited to bring together her expertise in antibody engineering and solid tumors with the Cochran Lab’s yeast display platform to advance the development of innovative new cancer therapies.

Welcome, Suruchi!